Genedrive (GDR) Short Positions
Add to Alert list

Active Short Positions

Holder Position Change Date
No active short positions

Historical Short Positions

Holder Position Change (%) Date
GSA Capital Partners LLP 0.56% -0.13 16-Jan-2023 View History
GSA Capital Partners LLP 0.69% -0.08 11-Jan-2023 View History
GSA Capital Partners LLP 0.77% -0.12 09-Jan-2023 View History
GSA Capital Partners LLP 0.89% -0.02 04-Jan-2023 View History
GSA Capital Partners LLP 0.91% 08-Apr-2022 View History
GSA Capital Partners LLP 0.8% 04-Apr-2022 View History
GSA Capital Partners LLP 0.7% 29-Mar-2022 View History
GSA Capital Partners LLP 0.62% 25-Mar-2022 View History
GSA Capital Partners LLP 0.52% 17-Feb-2022 View History

Genedrive plc is a medical equipment company based in Manchester, UK that develops and sells point-of-care molecular diagnostic platforms. Their products are used in healthcare settings, particularly in emergency medicine, for patient stratification and disease detection. Genedrive's goal is to improve clinical outcomes with easy-to-use tests. 

 Genedrive's major products include:
Genedrive CYP2C19 ID Kit: A rapid test that establishes metaboliser status in time-critical settings
Genedrive MT-RNR1 ID Kit: The world's first point-of-care genetic test to reduce the risk of aminoglycoside induced hearing loss

Genedrive was founded on contract research services for pharmaceutical and biotech companies, and was originally named Epistem Holdings Inc. when it was floated on the London AIM market in 2007. The company was renamed genedrive plc in 2016 to reflect its new focus on molecular diagnostics, and divested its contract research services divisions in 2018.

GDR share price launched at 129p in 2007. 

Note: This description is in part generated by AI and not an endorsement by or the opinion of Investegate
UK 100
FTSE quotes by TradingView

Latest directors dealings

All directors dealings today